SCHEMBL5364712

SCHEMBL5364712

N#Cc1ccc2ncc3ccccc3c2c1C#N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.44
▸ GPR3 P46089 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.43
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ GAA P10253 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ CACNA1B Q00975 1/20 0.38
▸ APBA1 Q02410 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9020442 0.81 KDM4E (0.52) KDM4EGPR3ALDH1A1CYP11B1CYP11B2
SCHEMBL159416 0.74 KDM4E (0.59) KDM4EGPR3ALDH1A1MAPTMEN1
SCHEMBL31684807 0.74 KDM4E (0.59) KDM4EGPR3ALDH1A1MAPTMEN1
Hydrochloric Acid SCHEMBL9110426 0.72 KDM4E (0.57) KDM4EGPR3ALDH1A1MAPTMEN1
SCHEMBL646163 0.70 CA1 (0.52) KDM4EALDH1A1GAAMAPTMEN1
SCHEMBL9038627 0.69 KDM4E (0.59) KDM4EGPR3ALDH1A1HTTMAPT
SCHEMBL25487988 0.68 KDM4E (0.54) KDM4EALDH1A1CYP11B2LRRK2HTT
SCHEMBL1773061 0.68 KDM4E (0.46) KDM4EGPR3ALDH1A1CYP11B1CYP11B2
SCHEMBL29780666 0.68 CYP3A4 (0.58) KDM4EGPR3ALDH1A1HTTMAPT
SCHEMBL14311585 0.68 KDM4E (0.48) KDM4EGPR3ALDH1A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7226924-B2 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use GRUENENTHAL GMBH (DE) 2007-06-05 — — US disclosed
US-20030220322-A1 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use GRUENENTHAL GMBH (DE) 2003-11-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220322-A1 Substituted 3,4-dihydro-pyrimido[1,2a]pyrimidines and 3,4-dihydro-pyrazino[1,2a]pyrimidines, and methods for their preparation and use DPYD, P2RX5, P2RX2 KDM4E 3131/4885GPR3 856/4885ALDH1A1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback